Patient Compliance Executive Conference On Industry Adoption Of New Tools To Feature 25 Pharma Company Speakers, April 4-5
Main Category: Pharma Industry / Biotech IndustryAlso Included In: Public Health; Compliance
Article Date: 04 Feb 2006 - 7:00 PDT
| Patient / Public: | ![]() |
|
| Healthcare Prof: | ![]() |
3 (1 votes) |
Integrating Patient Compliance: Plugging the Hole in the Bucket, will bring together the largest assembly of pharmaceutical company speakers and attendees in recent memory as the Industry has begun to adopt new ways of addressing a stubborn problem that takes its toll on the country's health, the healthcare system, and Industry performance. The total societal problem of non-compliance is estimated to cost $100 billion a year, according to Strategic Research Institute.
The conference is remarkable in that new strategies and tools are finally being developed and adopted to ensure a higher rate of compliance and will be presented by an equally remarkable number of pharmaceutical companies. Speakers include executive personnel from GlaxoSmithKline, AstraZeneca, Pfizer, Merck, Berlex, Amylin, Sanofi-Aventis, Bristol-Myers Squibb, Johnson & Johnson, MedImmune, Ortho McNeil, Indevus, Daiici, Sankyo, Centocor, Genzyme, Millennium, Coley Pharma, Elan, and Wyeth.
The conference is one of six two-day tracks within the much larger "Pharmaceutical Marketing & Sales Summit," that is expected to draw between 400-600 attendees. Attendees may customize their experience session-by-session and the exceptionally large number of Pharma attendees is facilitated by the value in the options and breadth of marketing coverage. The total number of speakers for the Summit will surpass 100.
The Summit is enhanced by the shared networking breaks, nightly entertainment, and exceptional networking opportunities.
To request the agenda in pdf format, contact Seth Fritts, the organizer at sfritts@srinstitute.com or at 212.967.0095, Ext. 256.
Speaking opportunities remain and may be coordinated with sponsorship and exhibition. Exhibitors may benefit from the Pharma-intensive show by having an on site presence to attract new business.
Contact Mark Alexay at malexay@srinstitute.com or 212.967.0095, extension 251 to determine what level of exposure works best for your company. The number of Pharma client prospects is unpredented. Register now for the best space.
To learn about becoming a media partner, please email Cheryl Kahan-Radhuber at ckahan-radhuber@srinstitute.com or telephone Cheryl at 212.967.0095, Ext. 273.
Strategic Research Institute
http://www.srinstitute.com
Visit our pharma industry / biotech industry section for the latest news on this subject.
MLA
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/37123.php>
APA
http://www.medicalnewstoday.com/releases/37123.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




